Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
30 beneficiaries avail of services per minute
Subscribe To Our Newsletter & Stay Updated
